Sexual Behavior Before and After Pregnancy Detection in Four Microbicide Trials
Authors:
- Paul J. FeldblumPFPaul J. Feldblum
- Silver L. WevillSWSilver L. Wevill
- 6 December 2011
- journal article
- research article
- Published by Springer Nature in AIDS and Behavior
- Vol. 16 (7) , 1830-1835
Abstract
Vaginal microbicide gel trials for HIV prevention may require withdrawal of study product when a woman becomes pregnant. We assessed the potential impact of withdrawals in four trials by comparing self-reported sexual behavior pre- and post-pregnancy detection: (1) behavior in the month prior to positive pregnancy test versus behavior reported at the subsequent monthly visit; (2) behavior changes according to pregnancy status at the subsequent visit (continuing pregnancy versus not); (3) average sexual behaviors reported for all months prior to pregnancy detection versus all months after pregnancy was no longer detected; and (4) behavior changes among participants never testing positive for pregnancy. Pregnancy detection was associated with immediate reductions in self-reported numbers of partners and sex acts. The proportion of acts in which study gel was used following a negative pregnancy test did not return to pre-pregnancy levels. Pregnancies complicate the conduct and interpretation of vaginal microbicide trials when product must be withdrawn.Keywords
This publication has 15 references indexed in Scilit:
- Contraceptive Efficacy, Acceptability, and Safety of C31G and Nonoxynol-9 Spermicidal GelsObstetrics & Gynecology, 2010
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviewsJournal of Clinical Epidemiology, 2009
- Effectiveness of Cellulose Sulfate Vaginal Gel for the Prevention of HIV Infection: Results of a Phase III Trial in NigeriaPLOS ONE, 2008
- Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV TransmissionNew England Journal of Medicine, 2008
- Noncomparative Contraceptive Efficacy of Cellulose Sulfate GelObstetrics & Gynecology, 2008
- SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in NigeriaPLOS ONE, 2008
- SAVVY® (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in GhanaPLOS ONE, 2007
- Trends in Sexually Transmitted Diseases, Sexual Risk Behavior, and HIV Infection Among Asian/Pacific Islander Men Who Have Sex With Men, San Francisco, 1999–2005Sexually Transmitted Diseases, 2007
- Validity of self-reported 'safe sex' among female sex workers in Mombasa, Kenya—PSA analysisInternational Journal of STD & AIDS, 2007